Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_775_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Introduction
- •Contents
- •Contributors
- •1.5 Venous Anatomy
- •1.6 Conclusion
- •References
- •2.1 Introduction
- •2.1.1.1 IPDA
- •1.1 Introduction
- •1.2 Arterial Anatomy
- •1.3 Portal Venous Anatomy
- •1.4 Biliary Anatomy
- •2.1.1.4 Dorsal Pancreatic Artery (DPA)
- •2.3 Surgical Techniques
- •2.4 Discussion
- •2.5 Conclusion
- •References
- •3.1 Introduction
- •3.2 Intrahepatic Biliary Tract
- •3.2.4 Accessory Biliary Ducts
- •3.3 Extrahepatic Biliary Tract
- •3.3.2 Retroduodenopancreatic Portion
- •3.3.3 Intramural Portion
- •3.5 Accessory Biliary Tract
- •3.5.2 Vascularization
- •References
- •4.1 Introduction
- •4.2 Posthepatectomy Liver Failure (PHLF)
- •4.3.1 Portal Hypertension
- •4.3.3 Blood Chemistry Tests
- •4.3.4 Indocyanine Green (ICG) Clearance Test
- •4.4 M2BPGi
- •4.5 Scintigraphy
- •4.7 Measuring FLR Function
- •4.8 Conclusions
- •References
- •5.1.1 Hemangioma
- •5.1.2 Focal Nodular Hyperplasia
- •5.1.3 Simple Hepatic Cyst
- •5.1.4 Hepatic Adenoma
- •5.2.1 Hepatocellular Carcinoma
- •5.2.2 Metastatic Disease
- •5.2.3 Intrahepatic Cholangiocarcinoma
- •5.2.4 Hepatic Angiosarcoma
- •5.3.1 Acute Calculous Cholecystitis
- •5.3.2 Chronic Cholecystitis
- •5.3.3 Acalculous Cholecystitis
- •5.3.4 Biliary Dyskinesia
- •5.3.5 Choledocolithiasis
- •5.3.7 Choledochal Cysts
- •5.3.8 Primary Sclerosing Cholangitis
- •5.3.9 Benign Biliary Stricture
- •5.4.1 Extrahepatic Cholangiocarcinoma
- •5.4.2 Gall Bladder Cancer
- •5.5.1 Acute Pancreatitis
- •5.5.2 Chronic Pancreatitis
- •5.5.3 Pancreas Neuroendocrine Tumors
- •5.5.4 Pancreas Cystic Neoplasms
- •5.5.4.1 Intraductal Papillary Mucinous Neoplasm
- •5.5.4.2 Mucinous Cystic Neoplasm
- •5.5.4.3 Solid Pseudopapillary Neoplasm
- •5.6.1 Pancreas Adenocarcinoma
- •References
- •6.2.1 Gallbladder
- •6.3.1 Gallbladder Dysfunction
- •6.3.3 Pancreaticobiliary Maljunction
- •6.4.2 Enterohepatic Circulation
- •6.4.3 Bile Acids
- •References
- •7.1 Introduction
- •BilINs
- •IPNBs
- •7.1.1.2 Imaging Findings
- •BilINs
- •IPNB
- •7.1.2.1 Gross
- •BilIN
- •IPNB
- •Controversial Cases: BilIN or IPNB
- •7.1.2.2 Histologies
- •BilINs
- •IPNB.
- •8.4 Gallbladder Carcinoma
- •8.4.1 Gross Features
- •8.4.2 Microscopic Features
- •8.4.3 Molecular Features
- •References
- •BilIN
- •IPNB
- •7.1.4.1 BilIN
- •7.1.4.2 IPNB
- •7.2 Conclusion
- •References
- •8.1 Introduction
- •8.2 Intrahepatic Cholangiocarcinoma
- •8.2.1 Gross Features
- •8.2.2 Microscopic Features
- •8.2.3 Molecular Features
- •8.3 Extrahepatic Cholangiocarcinoma
- •8.3.1 Gross Features
- •8.3.2 Microscopic Features
- •8.3.3 Molecular Features
- •References
- •10.1.2 Epidemiology
- •10.1.3 Etiology
- •10.1.4 Clinical Features
- •10.1.5 Radiology
- •10.1.6 Pathology
- •10.1.6.1 Macroscopic Appearance
- •10.1.6.3 Immunohistochemistry
- •10.1.6.4 Grading
- •10.1.6.6 Molecular Pathology
- •10.2.2 Epidemiology
- •10.2.3 Etiology
- •10.2.4 Clinical Features
- •10.2.5 Radiology
- •10.2.6 Pathology
- •10.2.6.1 Macroscopic Appearance
- •10.2.6.2 Microscopic Appearance
- •10.2.6.3 Immunohistochemistry
- •10.2.6.5 Molecular Pathology
- •10.3.2 Epidemiology
- •10.3.3 Etiology
- •10.3.4 Clinical Features
- •10.3.5 Radiology
- •10.3.6 Pathology
- •10.3.6.1 Macroscopic Appearance
- •10.3.6.3 Immunohistochemistry
- •10.3.6.5 Molecular Pathology
- •References
- •11: Mucinous Cystic Neoplasms
- •11.1 Introduction
- •11.2 Clinical Aspects
- •11.3 Pathological Findings
- •11.3.1 Macroscopical Features
- •11.3.2 Histological Features
- •11.4 Molecular Abnormalities
- •References
- •12.1 Introduction
- •12.1.1 General Features
- •12.1.2 Diagnostic Features
- •12.1.3 Clinical Implications
- •12.1.4 Desmoplastic Stroma
- •12.1.5 Venous Invasion
- •12.1.6 Variants
- •12.2 Conclusions
- •References
- •13.2.1 Benign Liver Tumors
- •13.2.2 Malignant Liver Tumors
- •13.2.3.1 Liver Abscess
- •13.4.1 Biliary Tree Tumors
- •13.5.1 Pancreatic Tumors
- •References
- •14.1 MRE Technique
- •14.2 MRE Performance
- •14.4 Technical Limitations
- •14.5 Summary
- •References
- •15.1 Introduction
- •15.6 Conclusion
- •References
- •17.1 Intraoperative Cholangiography
- •17.2 Intraoperative Ultrasound
- •17.2.1 Anatomy
- •17.2.2 Diagnosis
- •17.2.3 Resection Guidance
- •17.2.3.2 Resection Guidance
- •17.3 Intraoperative Fluorescence Imaging
- •17.4 Navigation Assisted Liver Resection
- •References
- •18.1 Introduction
- •18.2 Photon Therapy
- •18.3 Charged Particles Therapy
- •18.4 MRI Guided Therapy
- •18.5 Combination Strategies Using Cytotoxics
- •18.6 Radioimmunotherapy
- •18.8 Summary
- •References
- •19.1 Introduction
- •19.2 Systemic Chemotherapy
- •19.2.1 Adjuvant Therapy
- •19.2.2 First-Line Therapy
- •19.2.3 Second-Line Therapy
- •19.3 Targeted Therapy
- •19.4 Immunotherapy
- •19.5 Precision Medicine
- •References
- •20.1 Introduction
- •20.2.1 Neoadjuvant Chemotherapy
- •20.2.2 Adjuvant Chemotherapy
- •20.2.3 Palliative Chemotherapy
- •20.3 Immunotherapy
- •20.4 Tumor Microenvironment
- •20.5 Summary
- •References
- •21.1 Background
- •21.5 Combination Strategies
- •21.7 Future Perspectives
- •References
- •22.1 FGFR Alterations
- •22.2 IDH Mutations
- •22.3 BRAF Alterations
- •22.7 Conclusions
- •References
- •23.1 Introduction
- •23.2 Adjuvant Systemic Therapy
- •23.3 Neoadjuvant Systemic Therapy
- •23.4.3 Second-Line Therapy
- •23.4.4 Targeted Therapy
- •References
- •24.1 Introduction
- •24.4 The Various Stents Available
- •24.8 Hilar Strictures (Resectable Cases)
- •24.9 Hilar Stricture: Palliative Cases
- •24.11 Endoscopic Ultrasound-Guided Biliary Drainage
- •24.12 Conclusions
- •References
- •25.1 Introduction
- •25.3 EUS-TD Technique
- •25.4 EN Technique
- •25.6 Conclusion
- •References
- •26.1 Background
- •26.2 Short History
- •26.4.6 Personalized Cancer Treatment
- •References
- •27.1 Introduction
- •27.3.1 Pre-Admission Optimization
- •27.3.3 Carbohydrate Loading
- •27.3.6 Early Feeding
- •27.6 Conclusion
- •References
- •28.1 Introduction
- •28.5 Conclusion
- •References
- •29.6 Conclusion
- •References
- •30.1 Introduction
- •30.3 Surgical Indication
- •30.4 Surgical Technique
- •30.4.1 Exposure
- •30.4.4 Parenchymal Transection
- •30.5 Clinical Advantages
- •30.5.1 Technical Advantages
- •30.5.2 Prognostic Advantages
- •30.6 Conclusions
- •References
- •31.1 Introduction
- •31.2 Multiple Bilobar CLM
- •31.2.1 Intraoperative Ultrasound
- •31.2.2 Tumor-vessel Detachment
- •31.2.3 Communicating Veins
- •31.3 New Procedures
- •31.3.1.1 Eligibility Criteria
- •31.3.2 Upper Trasversal Hepatectomy (UTH))
- •31.3.2.1 Mini-Upper Transversal Hepatectomy
- •31.3.2.2 Right Upper Transversal Hepatectomy [33]
- •31.3.2.3 Left Upper Transversal Hepatectomy [24]
- •31.3.2.4 Total Upper Transversal Hepatectomy [24, 34]
- •Eligibility Criteria
- •31.3.3 Mini-mesohepatectomy (MMH) [35, 36]
- •31.3.3.1 Eligibility Criteria
- •31.3.4 Liver Tunnel [37, 38]
- •Eligibility Criteria
- •31.4 Discussion
- •31.5 Concerns & Future Directions
- •31.6 Conclusions
- •References
- •32.1 Introduction
- •References
- •33.1 Introduction
- •33.6 Segmentectomy, Cone Unit Resection
- •33.7 Surgical Outcomes
- •References
- •34.1 Introduction
- •34.6 Laparoscopic Parenchymal Sparing Anatomical Hepatectomy (Lap-PSAH)
- •34.7 Surgical Procedures at Ageo Central General Hospital (ACGH)
- •34.8 Conclusion
- •References
- •35.5 Laparoscopic Segmentectomy V (S5)
- •35.6 Laparoscopic Segmentectomy VI (S6)
- •35.7 Laparoscopic Segmentectomy VII (S7)
- •References
- •36: Modified ALPPS Procedure
- •36.1 Introduction
- •36.2 Discussion
- •36.2.1 Parenchymal Transection
- •36.2.2 Hepatoduodenal Ligament Dissection
- •36.2.4.1 Partial ALPPS
- •36.2.4.2 Hybrid ALPPS
- •36.2.4.3 Mini-ALPPS/ALPTIPS
- •36.2.4.5 Tourniquet ALPPS
- •36.3 Conclusion
- •References
- •37.1 Introduction
- •37.3 Right-Posterior Approach
- •37.4 Right-Uncinate Approach
- •37.5 Mesenteric Approach
- •37.6 Left-Posterior Approach
- •37.7 Anterior Approach
- •37.8 Mesopancreatic Resection
- •37.10 Summary
- •References
- •38: Organ- and Parenchyma-sparing Pancreatic Surgery
- •38.1 Introduction
- •38.2 Organ-Sparing Techniques
- •38.2.1 Spleen-Preserving Distal Pancreatectomy
- •38.3 Parenchyma-Sparing Techniques
- •38.3.2 Dorsal Pancreatectomy
- •38.3.4 Middle-Preserving Pancreatectomy
- •38.4 Conclusion
- •References
- •39.1 Introduction
- •39.2.1 Laparotomy
- •39.2.2 Supramesocolic Approach
- •39.2.3 Inframesocolic Approach
- •39.3 Mesenteric Incision
- •39.9 Antithrombogenic PV Catheter Bypass
- •39.13 Discussion
- •References
- •40.1 Introduction
- •40.4 HA Reconstruction
- •40.4.1 Simple Reconstruction Case
- •40.4.2 Complicated Reconstruction Case
- •40.4.3 Concomitant Vein Resection
- •40.4.4 Management after HA Reconstruction
- •40.5 Conclusions
- •References
- •41.1 Introduction
- •41.3.1 Patients
- •41.3.2 Preoperative Treatments
- •41.3.5 Statistical Analyses
- •41.4 Results
- •41.5 Discussion
- •References
- •42.1 Introduction
- •42.1.1 Preoperative Planning
- •42.2 Surgical Technique
- •42.2.1 Basic Preliminary Maneuvers
- •42.3 Postoperative Management
- •42.4 Conclusions
- •References
- •43: Robotic Pancreaticoduodenectomy
- •43.1 Background
- •43.2 Robotic PD
- •43.3 Conclusion
- •References
- •44: Duodenum-Preserving Pancreatic Head Resection
- •References
- •45.1 Introduction
- •45.2 Surgical Technique
- •45.3 Discussion
- •References
- •46: Spleen-Preserving Distal Pancreatectomy
- •46.1 Introduction
- •46.2 Indications
- •46.4 Technique
- •46.4.1 Warshaw’s Technique
- •46.5 Postoperative Follow-Up
- •References
- •References
- •48.1 Introduction
- •48.10 Surgical Technique Preserving Left Gastric Artery
- •48.12 Conclusions
- •References
- •49: Robotic Distal Pancreatectomy
- •49.1 Surgical Technique
- •49.1.3 Distal Splenopancreatectomy
- •49.1.4 Spleen-Preserving Distal Pancreatectomy
- •49.2 Results
- •49.3 Discussion
- •References
- •50: Total Pancreatectomy
- •50.1 Introduction
- •50.2 Indications
- •50.3 Surgical Procedure
- •50.4 Vascular Resection
- •50.5 Comment
- •References
- •References
- •52.1 Introduction
- •52.2.1 Non-Functional PNEN (NF-PNEN)
- •52.2.2 Functional PNEN
- •52.2.4 High-grade PNEN
- •52.4 Conclusions
- •References
- •53.1 Introduction
- •53.1.1 Fukuoka Guidelines 2012 (Revised 2017)
- •53.1.2 European Guidelines 2018 (EG18)
- •53.2 Discussion
- •References
- •54.1 Introduction
- •54.1.1 Developmental Mechanism
- •54.1.2 Designations
- •54.1.3 Incidence
- •54.1.4 Predictive Factors
- •54.1.5 Treatment
- •54.2 Conclusion
- •References
- •55: Benign Biliary Diseases
- •55.1 Introduction
- •55.2 Congenital Anomalies
- •55.2.1 Biliary Atresia
- •55.2.2 Choledochal Cyst
- •55.3 Diagnosis
- •55.4 Complications
- •55.5 Management
- •55.5.1 Gallstones
- •55.6 Pathogenesis
- •55.8 Complications
- •55.9 Bile Duct Stones
- •55.10 Management
- •55.11 Intrahepatic Stones
- •55.13.1 Benign Biliary Strictures (BBS)
- •55.14 Iatrogenic Biliary Injury
- •55.15 Mirizzi Syndrome (MS)
- •55.16 Liver Transplantation Related BBS
- •55.17 Primary Sclerosing Cholangitis (PSC)
- •55.17.1 Biliary Dyskinesia
- •References
- •56.1 Introduction
- •56.2 Preoperative Evaluation
- •56.2.1 Preoperative Biliary Drainage
- •56.2.2 Portal Vein Embolization
- •56.3.2 Hilar No Touch “En-bloc” Technique
- •56.3.3 Vascular Resection
- •56.3.4 Margin Status
- •56.3.5 Lymph Node Dissection
- •56.3.6 Minimally Invasive Surgery
- •56.4 Short-term Results
- •56.5 Long-term Results
- •56.6 Conclusions
- •Bibliography
- •57.1 Introduction
- •57.2 Clinical Presentation
- •57.3 Serum Tumor Markers
- •57.4 Imaging
- •57.5 Treatment
- •57.6 Surgical Management
- •57.6.1 Liver Resection
- •57.11 Surgical Resection Procedure
- •57.13.2 Long-Term Outcomes
- •57.14 Recurrence
- •57.14.1 Liver Transplantation
- •References
- •58.1 Introduction
- •58.1.2 Surgical Techniques
- •58.1.4 Outcomes After HPD
- •58.1.5 Practical Management During Surgery
- •References
- •59: Hepato-biliary Injuries
- •59.1 Etiology
- •59.4 Diagnosis
- •59.4.1 Clinical Presentation
- •59.4.2 Imaging
- •References
- •60.1 Background
- •60.2 Diagnostics
- •60.3 Treatment
- •60.3.1 Nonoperative Management
- •60.3.2 Interventional Treatment
- •60.3.3 Surgery
- •References
- •61.1 Historical Overview
- •61.2.1.1 Acute Liver Failure (ALF)
- •61.2.1.2 Chronic Liver Failure
- •61.2.3 MELD Exceptions
- •61.2.4 Other Standardized MELD Exceptions
- •61.2.4.1 Non-Standardized MELD Exceptions
- •References
- •62.3 Patient Assessment
- •62.4 Prognostic Factors
- •62.6 Extracorporeal Liver Support Systems
- •62.8 Conclusion
- •References
- •63.1 Introduction
- •63.2 Donation After Brain Death
- •63.3 Donors after Circulatory Death
- •63.4.1 Surgical Technique
- •63.4.1.1 Cross-clamping
- •63.4.2 Technical Variants
- •63.4.2.1 Split Liver Retrieval
- •63.4.2.2 En-bloc Liver-pancreas Retrieval
- •63.4.2.3 En-bloc Liver-bowel Retrieval
- •63.4.3 Back-table
- •63.4.3.1 Incidents: Accidents
- •References
- •64.1 Introduction
- •64.11 Conclusions
- •References
- •65: Living Donor Liver Transplantation
- •65.1 Introduction
- •65.2.1 Graft Size
- •65.2.2 Left Liver Graft
- •65.2.3 Right Liver Graft
- •65.2.4 Right Lateral Sector Graft
- •65.2.5 Dual Graft
- •65.2.6 ABO Blood Type Incompatible Graft
- •References

bc
31 Parenchyma-sparing Hepatic Resection forMultiple Metastatic Tumors
251
31.3.3 Mini-mesohepatectomy (MMH) [35, 36]
This procedure represents an alternative to the conventional
meso-hepatectomy in case of tumors invading the MHV at
its caval conuence, and consists in a limited resection
including the tract of the invaded vein without its reconstruction sparing part of the segment 4 and/or of the right anterior
section.
31.3.3.1 Eligibility Criteria
Patients suitable for the MMH are those with tumors having
macroscopic signs of vascular invasion (preoperative imaging and IOUS) of the MHV close to the hepato-caval conuence (within 4cm) in presence of CVs between the MHV
and the RHV and/or LHV.
a
MHV
31.3.4 Liver Tunnel [37, 38]
This procedure represents an extension of the MMH, includ-
ing the total removal of segment 1. The following subtypes
can be recognized:
31.3.4.1 Liver Tunnel Without Resection
oftheMiddle Hepatic Vein
Limited or anatomic resection of S8 associated with complete removal of S1 (Fig.31.3).
31.3.4.2 Liver Tunnel withtheResection
oftheMiddle Hepatic Vein
Limited or anatomic resection of S4s-8 with section of middle HV and complete removal of S1. The outow of S5 and
MHV
T1
RHV
T2
RHV
Gp8
T2
RHV
Gp8
T2
RHV
RHV
Gp8s
IVC
Gp6
T3
T4
MHV
Fig. 31.3 (a) MRI images of a patients carrier of multiple colorectal
liver metastases (T); (b) a mid-term phase during liver dissection: yellow arrows represent the directions of the dissections. (c) cut surfaces at
the end of the resection representing a liver tunnel without middle
hepatic vein (MHV) resection. RHV Right Hepatic Vein, LHV Left
Hepatic Vein, IVC Inferior vena cava, Gp glissonean pedicles (numbers
refer to the segment fed; “s” means stump), IVC Inferior vena cava

252
B. Branciforte et al.
S4i is provided by CVs between the MHV and the RHV and/
31.4 Discussion
or LHV (Fig.31.4).
Sculpturing rather than simply dividing the liver has induced
Eligibility Criteria
Patients eligible for this approach are those with tumoral
involvement of segments 8, 4 superior, and 1, with eventual contact with MHV, and the RHV at caval conuence,
the right, and the left 1st and 2nd order portal branches.
The MHV could be invaded by the tumor at its caval conuence, in presence of CVs between the MHV, the RHV
and/or the LHV.
a revision of the concept of minor and major hepatectomy
[39], and denitely a new dictionary of liver surgery to be
written.
Moreover, other than technical insights and new terminologies, overcoming dogmas as tumor exposure mainly
launches new horizons for liver surgery, and more therapeutic options for the patients. In a comparative analysis between
E-OSH and TSH, E-OSH shows survivals similar to those of
ab
MHV
T
IVC
RHV
Gp6- 7
MHVs
LHV
LGP
Gp5- 8
c
RHV
IVC
Fig. 31.4 (a) CT image of a patients carrier of large colorectal liver
metastases (T) in tight relation with the right hepatic vein (RHV) and
the middle hepatic vein (MHV); (b) at color ow IOUS communicating
veins (CV) are evident between the RHV and the MHV; dotted line is
highlighting the CV path. (c) cut surface at the end of the resection
representing a liver tunnel MHV resection. RHV Right Hepatic Vein,
LHV Left Hepatic Vein, LGP left glissonean pedicle, IVC Inferior vena
cava, Gp glissonean pedicle (numbers refer to the segment/section fed),
IVC Inferior vena cava

31 Parenchyma-sparing Hepatic Resection forMultiple Metastatic Tumors
253
completed TSH but without the non-negligible 40% rate of
dropout, which mainly affected cumulative survival in TSH
group in an intention to treat perspective [40]. On the other
hand, a more recent multicenter case-match analysis suggests that ALPPS and E-OSH may achieve comparable longterm results in patients affected by bilobar CLM, despite a
higher mortality and morbidity rate after ALPPS [41]. A
safer clinical outcome after major tissue deprivation in a
parenchyma sparing vessel guided fashion compared to that
following major resections through conventional vessels
amputation should deserve some consideration. On the other
hand, ALPPS has shown to be associated with an increment
in liver volume which does not translate one to one with liver
function [42]. PSVGH keeping the architecture of the organ
with its major vessels even in presence of high amount of
liver tissue removed as it happens in case of multiple complex resection for bilobar CLM has shown a low risk and in
particular a low rate of liver failure: milder regeneration of
the liver after PSVGH compared to that evident after major
amputation of the organ should be considered as a possibility
to be investigated. Through IOUS and vessel guidance, PSS
has entered the complexity, and entering the complexity has
arrived to a different way of large tissue deprivation: the
parenchymal sparing major hepatectomies could be a meaningful and promising paradox.
31.5 Concerns & Future Directions
Despite all these strengths and potentialities, the future of
PSVGH in the clinical practice worldwide remains somehow
suspended.
PSS can limit the sacrice of parenchyma; this policy,
however, often results in resection margins of 0mm, which
could reach up to 30% of patients [43]. However, PSS and
non-PSS had comparable positive margin rates [44].
Furthermore, it has been demonstrated that rather than
millimeters, tumor biology is a more important predictor of
both intrahepatic or any other site recurrence and overall survival [27]. On the other hand, in patients with CLMs, occult
microscopic metastases are denitely uncommon [45, 46].
All of that, supports the concept of performing limited,
wedge resections with narrow margins for CLM, rather than
non-PSS procedures featured by worse postoperative outcome [47–49].
Technically sophisticated, PSVGH is moreover based on
the man-power resources rather than on the availability of a
sophisticated technology and dedicated devices: an ultrasound system, a Kelly-clamp, a Metzenbaum scissor, and
few more are enough. Therefore, in this viewpoint its cost is
low and its applicability wide, which sounds undoubtedly
positive on a certain perspective. However, its independence
from any highly technological equipment, makes the interest
of the health industry relatively low which for sure does not
help its diffusion. In this sense, its partial applicability in the
minimal access liver surgery (MALS), which attracts most of
the investments of the health industry, does not help in terms
of visibility within the surgical community. The inability of
MALS to address complex a multiplanar dissections, but the
possibility to perform even staged procedures [50] for sure
does not represent an incentive for the spread of
PSVGH.Furthermore, as rst impression PSVGH seems a
modality requiring an adequate training and for that it should
rely on a tutorship which to now is lacking. Inversely,
although an isolated experience, learning curve for this
approach resulted as long as that of any conventional
approach in liver surgery. Indeed, in author’s center a team
featured by a mean age of 36years old could cover autonomously up to 80% of surgical procedure carried out on a
yearly basis within 5–6years from his rst exposure [51].
31.6 Conclusions
In the 80s Masatoshi Makuuchi introduced the anatomical
parenchymal sparing hepatectomy opening to conservative
surgery those patients normally operated with risky major
anatomical resections [21]. In the 90s Henri Bismuth proposed to “resect the unresectable” introducing the concept of
conversion chemotherapy [52]. PSVGH has extended PSS to
the high complexity, further challenging to “resect the unresectable” just with a new surgical paradigm: the paradox of
parenchyma sparing major hepatectomy.
References
1. Vibert E, Pittau G, Gelli M, etal. Actual incidence and long-term
consequences of posthepatectomy liver failure after hepatectomy
for colorectal liver metastases. Surgery. 2014;155:94–105.
2. Adam R, Laurent A, Azoulay D, et al. Twostage hepatectomy:
a planned strategy to treat irresectable liver tumors. Ann Surg.
2000;232:777–85.
3. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC,
Bachellier P. A two-stage hepatectomy procedure combined with
portal vein embolization to achieve curative resection for initially
unresectable multiple and bilobar colorectal liver metastases. Ann
Surg. 2004;240(6):1037–49.
4. Wicherts DA, Miller R, de Haas RJ, etal. Long-term results of twostage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994–1005.
5. Schnitzbauer AA, Lang SA, Goessmann H, etal. Right portal vein
ligation combined with in situ splitting induces rapid left lateral
liver lobe hypertrophy enabling 2-staged extended right hepatic
resection in small-for-size settings. Ann Surg. 2012;255:405–14.
6. De Santibañes E, Clavien PA. Playing Play-Doh to prevent
postoperative liver failure: the “ALPPS” approach. Ann Surg.
2012;255:415–7.

254
B. Branciforte et al.
7. Schadde E, Ardiles V, Robles-Campos R, etal. Early survival and
safety of ALPPS: rst report of the International ALPPS Registry.
Ann Surg. 2014;260:829–36.
8. Guiu B, Quenet F, Escal L, etal. Extended liver venous deprivation
before major hepatectomy induces marked and very rapid increase
in future liver remnant function. Eur Radiol. 2017;27(8):3343–52.
9. Laurent C, Fernandez B, Marichez A, etal. Radiological simultaneous portohepatic vein embolization (RASPE) before major hepatectomy: a better way to optimize liver hypertrophy compared to
portal vein embolization. Ann Surg. 2020;272(2):199–205.
10. Gold JS, Are C, Kornprat P, Jarnagin WR, Gönen M, Fong Y,
DeMatteo RP, Blumgart LH, D’Angelica M. Increased use of
parenchymal-sparing surgery for bilateral liver metastases from
colorectal cancer is associated with improved mortality without
change in oncologic outcome: trends in treatment over time in 440
patients. Ann Surg. 2008;247:109–17.
11. Chouillard E, Cherqui D, Tayar C, Brunetti F, Fagniez
PL.Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann Surg. 2003;238(1):29–34.
12. Torzilli G, Montorsi M, Donadon M, etal. “Radical but conservative” is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg.
2005;201(4):517–28.
13. Torzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M,
Makuuchi M. Ultrasonographically guided surgical approach to
liver tumours involving the hepatic veins close to the caval conuence. Br J Surg. 2006;93(10):1238–46. https://doi.org/10.1002/
bjs.5321.
14. Torzilli G, Procopio F, Botea F, et al. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach.
Surgery. 2009;146(1):60–71.
15. Viganò L, Costa G, Procopio F, Donadon M, Cimino M, Del
Fabbro D, Gatti A, Torzilli G.Parenchyma-sparing liver surgery
for large segment 1 tumors: ultrasound-guided lateral and superior
approaches as safe alternatives to major hepatectomy. J Am Coll
Surg. 2015;221(4):e65–73.
16. Torzilli G, Viganò L, Gatti A, Costa G, Cimino M, Procopio F, etal.
Twelve-year experience of “radical but conservative” liver surgery
for colorectal metastases: impact on surgical practice and oncologic
efcacy. HPB. 2017;19:775–84.
17. Torzilli G, Procopio F, Viganò L, Cimino M, Costa G, Del Fabbro
D, Donadon M.Hepatic vein management in a parenchyma-sparing
policy for resecting colorectal liver metastases at the caval conuence. Surgery. 2018;163(2):277–84.
18. Torzilli G, Cimino MM. Extending the limits of resection
for colorectal liver metastases enhanced one stage surgery. J
Gastrointest Surg. 2017;21:187–9.
19. Vigano L, Ferrero A, Lo Tesoriere R, et al. Liver surgery for
colorectal metastases: results after 10 years of follow-up. Longterm survivors, late recurrences, and prognostic role of morbidity.
Ann Surg Oncol. 2008;15:2458–64.
20. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year
survival after resection of colorectal liver metastases denes cure. J
Clin Oncol. 2007;25:4575–80.
21. Makuuchi M, et al. Ultrasonically guided liver surgery. Jpn J
Ultrasonics Med. 1980;7:45–9.
22. Kneuertz PJ, Pitt HA, Bilimoria KY, et al. Risk of morbidity and mortality following Hepato-Pancreato-biliary surgery. J
Gastrointest Surg. 2012;16:1727–35.
23. Torzilli G, Procopio F, Costa G. Adjuncts to hepatic resection–
ultrasound and emerging guidance systems. In: Jarnagin WR, editor. Blumgart’s surgery of the liver, pancreas, and biliary tract. 6th
ed. Philadelphia: Elsevier Saunders; 2017.
24. Torzilli G.Ultrasound-guided liver surgery: an atlas. 1st ed. Milan:
Springer-Verlag; 2014.
25. Torzilli G, etal. Does contrast-enhanced intraoperative ultrasonography impact radicality of hepatectomies for colorectal cancer liver
metastases in spite of modern preoperative imaging? Analysis on a
prospective cohort. Eur J Cancer. 2008;6:16–23.
26. Pawlik TM, Scoggins CR, Zorzi D, etal. Effect of surgical margin
status on survival and site of recurrence after hepatic resection for
colorectal metastases. Ann Surg. 2005;241:715–22.
27. Viganò L, Procopio F, Cimino M, et al. Is tumor detachment
from vascular structures equivalent to R0 resection in surgery for
colorectal liver metastases? An observational cohort. Ann Surg
Oncol. 2016;23:1352–60.
28. Torzilli G, Garancini M, Donadon M, Cimino M, Procopio F,
Montorsi M. Intraoperative ultrasonographic detection of communicating veins between adjacent hepatic veins during hepatectomy for tumours at the hepatocaval conuence. Br J Surg.
2010;97(12):1867–73.
29. Torzilli G, Viganò L, Gatti A, et al. Twelve-year experience of
“radical but conservative” liver surgery for colorectal metastases:
impact on surgical practice and oncologic efcacy. HPB (Oxford).
2017;19(9):775–84.
30. Torzilli G, Donadon M, Marconi M, Botea F, Palmisano A, Del
Fabbro D, Procopio F, Montorsi M.Systematic extended right posterior sectionectomy: a safe and effective alternative to right hepatectomy. Ann Surg. 2008;247(4):603–11.
31. Makuuchi M, Hasegawa H, Yamazaki S, Takayasu K. Four new
hepatectomy procedures for resection of the right hepatic vein and
preservation of the inferior right hepatic vein. Surg Gynecol Obstet.
1987;164(1):68–72.
32. Torzilli G, Procopio F, Cimino M, Donadon M, Del Fabbro D,
Costa G, Gatti A, Garcia-Etienne CA. Radical but conservative
liver resection for large centrally located hepatocellular carcinoma: the mini upper-transversal hepatectomy. Ann Surg Oncol.
2014;21(6):1852.
33. Torzilli G, Procopio F, Donadon M, etal. Upper transversal hepatectomy. Ann Surg Oncol. 2012;19(11):3566.
34. Gentile D, Donadon M, Civilini E, Torzilli G.Total upper transversal hepatectomy with outow reconstruction for advanced
mass-forming cholangiocarcinoma. Updat Surg. 2021; https://doi.
org/10.1007/s13304- 020- 00946- 9. Epub ahead of print
35. Torzilli G, Botea F, Donadon M, Cimino M, Del Fabbro D,
Palmisano A.Minimesohepatectomy for colorectal liver metastasis invading the middle hepatic vein at the hepatocaval conuence.
Ann Surg Oncol. 2010;17(2):483. https://doi.org/10.1245/s10434-
009- 0728- 6. Epub 2009 Oct 23
36. Torzilli G, Palmisano A, Procopio F, etal. A new systematic small
for size resection for liver tumors invading the middle hepatic
vein at its caval conuence: mini-mesohepatectomy. Ann Surg.
2010;251(1):33–9.
37. Torzilli G, Cimino M, Procopio F, Costa G, Donadon M, Del
Fabbro D, Gatti A, Garcia-Etienne CA.Conservative hepatectomy
for tumors involving the middle hepatic vein and segment 1: the
liver tunnel. Ann Surg Oncol. 2014;21(8):2699.
38. Torzilli G, Procopio F, Viganò L, Costa G, Fontana A, Cimino
M, Donadon M, Del Fabbro D. The liver tunnel: intentionto-treat validation of a new type of hepatectomy. Ann Surg.
2019;269(2):331–6.
39. Viganò L, Torzilli G, Troisi R, etal. Minor Hepatectomies: focusing
a blurred picture: analysis of the outcome of 4471 open resections
in patients without cirrhosis. Ann Surg. 2019;270(5):842–51.
40. Torzilli G, Viganò L, Cimino M, etal. Is enhanced one-stage hepatectomy a safe and feasible alternative to the two-stage hepatectomy in the setting of multiple Bilobar colorectal liver metastases?
A comparative analysis between two pioneering centers. Dig Surg.
2018;35(4):323–32.
41. Torzilli G, Serenari M, Viganò L, etal. Outcomes of enhanced onestage ultrasound-guided hepatectomy for bilobar colorectal liver

31 Parenchyma-sparing Hepatic Resection forMultiple Metastatic Tumors
255
metastases compared to those of ALPPS: a multicenter case-match
analysis. HPB (Oxford). 2019;21(10):1411–8.
42. Olthof PB, Tomassini F, Huespe PE, etal. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: liver volume overestimates
liver function. Surgery. 2017;162(4):775–83.
43. van Dam RM, Lodewick TM, van den Broek MA, etal. Outcomes
of extended versus limited indications for patients undergoing a
liver resection for colorectal cancer liver metastases. HPB (Oxford).
2014;16(6):550–9.
44. Deng G, Li H, Jia GQ, Fang D, Tang YY, Xie J, etal. Parenchymalsparing versus extended hepatectomy for colorectal liver metastases: a systematic review and meta-analysis. Cancer Med.
2019;8(14):6165–75.
45. Kokudo N, et al. Genetic and histological assessment of surgical
margins in resected liver metastases from colorectal carcinoma:
minimum surgical margins for successful resection. Arch Surg.
2002;137(7):833–40.
46. Vigano L, Di Tommaso L, Mimmo A, Sollai M, Cimino M,
Donadon M, Roncalli M, Torzilli G. Prospective evaluation of
intrahepatic microscopic occult tumor foci in patients with numerous colorectal liver metastases. Dig Surg. 2019;36(4):340–7.
47. Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E,
Dillhoff M, Schmidt C, Pawlik TM.Parenchymal-sparing versus
anatomic liver resection for colorectal liver metastases: a systematic review. J Gastrointest Surg. 2017 Jun;21(6):1076–85.
48. Even Storli P, Johnsen G, Juel IS, Gronbech JE, Bringeland
EA. Impact of increased resection rates and a liver parenchyma
sparing strategy on long-term survival after surgery for colorectal
liver metastases. A population-based study. Scand J Gastroenterol.
2019;54(7):890–8.
49. Donadon M, Cescon M, Cucchetti A, etal. Parenchymal-sparing
surgery for the surgical treatment of multiple colorectal liver
metastases is a safer approach than major hepatectomy not impairing Patients' prognosis: a bi-institutional propensity score-matched
analysis. Dig Surg. 2018;35(4):342–9.
50. Melandro F, Giovanardi F, Hassan R, et al. Minimally invasive
approach in the setting of ALPPS procedure: a systematic review of
the literature. J Gastrointest Surg. 2019;23(9):1917–24.
51. Torzilli G, McCormack L, Pawlik T. Parenchyma-sparing liver
resections. Int J Surg. 2020;S1743-9191(20):30346.
52. Bismuth H, Adam R, Lévi F, etal. Resection of nonresectable liver
metastases from colorectal cancer after neoadjuvant chemotherapy.
Ann Surg. 1996;224(4):509–20.

Open andLaparoscopic Liver Hanging
Maneuver
JacquesBelghiti andSaDokmak
Abstract
In this chapter, we describe the liver hanging maneuver
(LHM) as a promising approach to facilitate and guide
anatomical liver resection. A blind dissection in the
avascular space situated in the central area of the vena
cava between the right hepatic vein (RHV) and the middle hepatic vein (MHV) allows the passage of a tape
whose traction suspend the liver. This suspension guides
the transection plane following anatomical liver resection; allows a better control of the surgical eld which
become more supercial; decreases blood loss through
traction/compression on the vessels especially when
associated with pedicle clamping; and facilitates the
oncologic “anterior approach”. This maneuver is considered as one of the main technical innovations in liver
surgery in the past two decades and is commonly adopted
as a very useful tool to assist major resection in open
surgery and, as practiced by some surgeons, in laparoscopic approach as well.
32
Fig. 32.1 Schema of the avascular plane by Couinaud. Surgical
Anatomy of the Liver, Revisited. Paris, France: 1989
32.1 Introduction
In 1953, the French anatomist surgeon Claude Couinaud,
studying the vascular and bile duct distribution in more than
hundred liver casts, demonstrated that the liver parenchyma
can be divided into eight autonomous segments [1]. When
scrutinizing the position of drainage of hepatic veins, he discovered a “loose cellular space” between the liver and the
J. Belghiti (*)
APHP Paris, Paris, France
e-mail: jacques.belghiti@aphp.fr
S. Dokmak
Department of HPB Surgery and Liver Transplantation, Beaujon
Hospital, Clichy, France
France University Paris VII, Paris, France
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022
M. Makuuchi et al. (eds.), The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases,
https://doi.org/10.1007/978-981-19-0063-1_32
inferior vena cava describing an avascular space in the central area of the vena cava (Fig.32.1). We used this space to
pass a long dissector along the anterior aspect of the retrohepatic IVC toward the space between the right hepatic vein
(RHV) and the middle hepatic vein (MHV), and described
this technique as the liver hanging maneuver (LHM) in 2001
[2]. Before any attempts to mobilize the liver, a clamp or a
nasogastric tube is introduced in this space permitting the
introduction of a tape whose traction suspend the liver. This
maneuver which is considered as one of the main technical
innovations in liver surgery in the past two decades, facilitate
liver transection [3]. Nowadays, LHM is commonly utilized
laparoscopic procedures.
257

258
IVC
32.2 Advantages ofLHM
J. Belghiti and S. Dokmak
Advantages of the LHM which were clearly demonstrated in
open surgery included (a) better assistance to guide transection plane following anatomical liver resection; (b) improved
control of the surgical eld which become more supercial;
(c) decreased blood loss through traction/compression on the
vessels especially when associated with pedicle clamping
and (d) facilitation of the oncologic “anterior approach”. The
oncologic advantage of anterior approach with LHM for
patients operated for HCC and CRLM was recently conrmed [4, 5]. Technical advantages of the LHM could impact
the surgical procedure allowing smaller incisions (such as
midline) when there is no need for right sided liver mobilization [6]. On the opposite side, in the presence of a right-side
large liver lesions with adhesions to the diaphragm this
maneuver simplied an anterior approach [7]. Some specic
situations such as donor liver harvesting and associating liver
partition and portal vein ligation for staged hepatectomy
(ALPPS) procedures which required parenchymal transection before transection of vascular and biliary structures are
facilitated by the LHM [8, 9].
32.3 Anatomical Basis oftheLHM
RHV
MHV
LHV
A
B
C
Fig. 32.2 General anatomic characteristics of the avascular plane of
retro hepatic IVC.A: constant large caudate vein; B: constant RIHV; C:
variables caudate short hepatic veins
The presence of a longitudinal avascular plane between the
IVC described by C. Couinaud was conrmed by several
anatomic studies since the rst description of our LHM [10,
11]. Some general characteristics of the anatomy of the retro
hepatic IVC remain constant including: (a) a constant large
caudate vein which is situated in the left of its the middle
portion; (b) a frequent right inferior hepatic vein (RIHV) in
the right side of the cranial part of the IVC; (c) caudate short
hepatic veins are variable in number, position and dimension
but most of them are sub millimetric (Fig.32.2).
32.4 Techniques ofLHM
In both open and laparoscopic procedures, the blind dissection can be started either from down to up or from up to
down. These two approaches required a short length of dissection of both supra and infra hepatic parts of the IVC.
In open surgery, the “Down to up” LHM was rst
described (Fig.32.3). The supra-hepatic IVC is exposed and
the space between the right hepatic vein (RHV) and the middle hepatic vein (MHV) is dissected along the IVC axis for
approximately 2–3cm length. The dissection of infra-hepatic
IVC is started after a retraction to the left of the hepatic pedicle and the plan between the peritoneal membrane between
the anterior aspect of the infra-hepatic IVC and the caudate
capsule is dissected toward the left side of the RIHV.If present some small hepatic veins are ligated and divided. The
blind dissection from down to up require a long, lightly
curved aortic clamp which is passed cranially along the anterior surface of the IVC between the 10 and 11 o’clock positions towards the space between the previously dissected
RHV and MHV.When the dissection is complete, the hepatic
parenchyma is looped up with a tape.
The “Up to Down “approach gradually replaced the previous one. The dissection of the space between the right and
middle hepatic veins is pushed down for 3–4cm with a rightangled vascular clamp. A recent anatomical publication of
the Glisson capsule emphasized the presence of two capsules
delimiting an avascular plan between the liver parenchyma
capsule and the capsule covering the vessels (Fig.32.4). A 16
Fr nasogastric tube is gently introduced and pushed caudally
to complete the dissection of the avascular space (Fig.32.5).
The rigidity of the nasogastric tube allows it to be used as a
dissector through the avascular space allowing an atraumatic
movement. After a dissection between the peritoneal membrane of the anterior aspect of the infra-hepatic IVC and the
caudate capsule, the nasogastric tube is collected in front of
IVC and can be immediately used as a tape. Very often, the
tube spontaneously emerges behind the inferior RHV.
In laparoscopic approach, the steps are broadly the same
as in the open approach [12–16]. However, after the creation

ab
32 Open andLaparoscopic Liver Hanging Maneuver
Fig. 32.3 Down to up LHM: (a) the blind dissection on the anterolateral surface of the IVC; (b) the tape allows traction facilitating liver
resection
Fig. 32.4 Gilson capsula: the
dissection plane of the LHM
(arrow) is between the
vascular and the parenchymal
capsula
259
of the pneumoperitoneum, a 10mm trocar is inserted into the
epigastric area and the falciform ligament is dissected along
the abdominal wall keeping enough tissue for traction [13].
This will enable dissection along the anterior aspect of the
supra-hepatic IVC and identication of the MHV and
RHV.The plane between the right and middle hepatic veins
is blindly dissected with a surgical dissector introduced
through the epigastric trocar. Dissection should be vertical,
aiming towards the anterior aspect of the IVC, rather than
tangentially in order to avoid injury to the right hepatic vein.
In larger patients with a big liver, we use a long open surgery
vascular clamp introduced through a 10mm skin incision.
The infra-hepatic dissection is similar to that of the open
approach. The nasogastric tube is introduced between the
MHV and the RHV to nalize the retro-hepatic blind dissection and is replaced by a surgical malleable tape allowing
easy manipulation [15]. The “Up-to-down” LHM seems also
to be easier and safer for the laparoscopic approach [15].
Although laparoscopy allows better direct visualization of
the area to be dissected, some laparoscopic surgeons are
reluctant to perform a blind dissection between the anterior
surface of the IVC and the liver and they stimulated the “lateral LHM variant” [17]. According to this technique, the
upper end of the hanging tape was placed on the lateral side
of the right or left hepatic vein and the lower end of the
hanging tape between three Glisson’s pedicles. The pathway

260
ab
Fig. 32.5 Up to down LHM. (a) Dissection is initiated on both sides of the liver. (b) A nasogastric tube is introduded in the cranio-caudal
direction
J. Belghiti and S. Dokmak
32.5 Variations ofLHM
Since the rst description of the LHM aiming to facilitate a
right hepatectomy extended to the right part of segment I
along the plane of the MHV, this maneuver has been utilized
in several indications including a living donor liver transplantation harvesting procedure, native liver resection in
transplantation, and partial resection of polycystic liver disease [10]. Many authors have applied the principles of this
maneuver LHM to facilitate various anatomical liver resections. The concept of anatomical LHM is dened by the passage of the surgical tape between two hepatic veins with a
surgical plane along the plane of a hepatic vein [6]. Depending
upon the type of resection required, the technique involves
extrahepatic dissection and isolation of the left, right anterior
Fig. 32.6 LHM allowing parenchymal transection before transection
of both vascular and biliary structures
of the tape was situated along the lateral side of the inferior
vena cava in right-sided hepatectomy or the ligamentum
venosum in left-sided hepatectomy [17]. When a vascular or
biliary reconstruction is required, the use of LHM in laparoscopic liver resection appears to be helpful as illustrated by
living donor procedure. LHM allowing parenchymal transection before transection of both vascular and biliary structures (Fig.32.6).
or right posterior Glisson’s pedicles. The possibility to use
two hanging tapes open several possibilities of central hepatectomies [18]. A concise summary of the various types of
anatomic liver resection are shown in Figs.32.7, 32.8, 32.9,
32.10, 32.11, 32.12, 32.13, 32.14, and 32.15.
32.6 Limits andContraindications
The only denite contraindication of the blind dissection of
the LHM is tumoral invasion of the anterior face of the IVC
and particularly the cava-hepatic junction. The presence of

32 Open andLaparoscopic Liver Hanging Maneuver
261
Fig. 32.7 Right Hepatectomy or Left Hepatectomy + S I.Upper end of
the tape: Between RHV & MHV, Lower end of the tape: Between Right
& Left portal pedicle
Fig. 32.9 Right trisectionectomy. Tape upper end: Between MHV &
LHV, Tape lower end: Between Right & Left portal pedicle
Fig. 32.8 Right posterior sectionectomy or Left trisectionectomy+ S
I.Upper end of the tape: Between RHV & MHV, Lower end of the tape:
Between Right anterior & Right posterior portal pedicle
adhesions between the IVC and liver resulting from redo surgery or severe inammation induced by chemoembolization
or portal vein embolization can increase the difculties [10].
Bleeding which may occur during the bind dissection is usually minimal and related to subcapsular liver dissection. A
temporal packing of the dissection area represents an ef-
Fig. 32.10 Right trisectioectomy + SI or Left lateral sectionectomy.
Tape upper end: Between MHV & LHV, Tape lower end: Between
Right & Left portal pedicle
cient treatment [3]. Severe bleeding from major veins injuries is rare and require an interruption of the maneuver
shifting to a classical approach of liver resection [3]. The
suppression of the venous outow induced by the traction on
the tape can disturb identication of hepatic veins. Therefore,
Соседние файлы в папке Библиотека им академика М.И. Перельмана
